Herb-drug, food-drug, nutrient-drug, and drug-drug interactions: Mechanisms involved and their medical implications

被引:53
作者
Sorensen, JM
机构
[1] Allinge DK-3770
关键词
D O I
10.1089/10755530260127989
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Adverse drug reactions (ADRs) and iatrogenic diseases have been identified as significant factors responsible for patient morbidity and mortality. Significant studies on drug metabolism in humans have been published during the last few years, offering a deeper comprehension of the mechanisms underlying adverse drug reactions and interactions. More understanding of these mechanisms, and of recent advances in laboratory technology, can help to evaluate potential drug interactions when drugs are prescribed concurrently. Increasing knowledge of interindividual variation in drug breakdown capacity and recent findings concerning the influence of environment, diet, nutrients, and herbal products can be used to reduce ADRs and iatrogenic diseases. Reviewed data suggest that drug treatment should be increasingly custom tailored to suit the individual patient and that appropriately co-prescribed diet and herbal remedies, could increase drug efficacy and lessen drug toxicity. This review focuses mainly on recently published research material. The cytochrome p450 enzymes, their role in metabolism, and their mechanisms of action are reviewed, and their role in drug-drug interactions are discussed. Drug-food and drug-herb interactions have garnered attention. Interdisciplinary communication among medical herbalists, medical doctors, and dietetic experts needs to be improved and encouraged. Internet resources for obtaining current information regarding drug-drug, drug-herb, and drug-nutrient interactions are provided.
引用
收藏
页码:293 / 308
页数:16
相关论文
共 98 条
[1]   Grapefruit juice-drug interactions [J].
Bailey, DG ;
Malcolm, J ;
Arnold, O ;
Spence, JD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :101-110
[2]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[3]  
BLAND SA, 1998, J PHARM SOC WISCONSI, V6, P28
[4]  
BOBROFF LB, 1988, AVOIDING FOOD DRUG I
[5]   In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine [J].
Chang, WH ;
Augustin, B ;
Lane, HY ;
ZumBrunnen, T ;
Liu, HC ;
Kazmi, Y ;
Jann, MW .
PSYCHOPHARMACOLOGY, 1999, 145 (01) :91-98
[6]   Clinton acts to reduce medical mistakes [J].
Charatan, F .
BRITISH MEDICAL JOURNAL, 2000, 320 (7235) :597-597
[7]   Extension of a pilot study: Impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness [J].
Chou, WH ;
Yan, FX ;
de Leon, J ;
Barnhill, J ;
Rogers, T ;
Cronin, M ;
Pho, M ;
Xiao, V ;
Ryder, TB ;
Liu, WW ;
Teiling, C ;
Wedlund, PJ .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (02) :246-251
[8]   Reporting of adverse drug reactions by poison control centres in the US [J].
Chyka, PA ;
McCommon, SW .
DRUG SAFETY, 2000, 23 (01) :87-93
[9]   Ways to minimize adverse drug reactions - Individualized doses and common sense are key [J].
Cohen, JS .
POSTGRADUATE MEDICINE, 1999, 106 (03) :163-+
[10]   THE INCIDENT REPORTING SYSTEM DOES NOT DETECT ADVERSE DRUG EVENTS - A PROBLEM FOR QUALITY IMPROVEMENT [J].
CULLEN, DJ ;
BATES, DW ;
SMALL, SD ;
COOPER, JB ;
NEMESKAL, AR ;
LEAPE, LL .
JOINT COMMISSION JOURNAL ON QUALITY IMPROVEMENT, 1995, 21 (10) :541-548